Catalog No. :
|
CL1108 |
Product Name :
|
Idarubicin Hydrochloride (Idarubicin HCl) |
CAS No. :
|
57852-57-0 |
Synonyms :
|
Idarubicin HCl | 4-demethoxydaunorubicin (NSC256439, 4-DMDR) HCl |
Chemical Name :
|
(7S,9S)-9-acetyl-7-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,9,11-trihydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrogen chloride |
Molecular Formula :
|
C26H27NO9.HCl |
Molecular Weight :
|
533.95 |
Molecular Structure :
|
|
Appearance :
|
Pink to red solid |
Specification :
|
98+% |
Application :
|
Topoisomerase inhibitor | Antibiotics inhibitor | Autophagy activator |
Registration :
|
|
Storage Condition :
|
4°C, sealed storage, away from moisture and light |
Idarubicin HCl is a hydrochloride salt form of Idarubicin which is an anthracycline antibiotic and a DNA topoisomerase II (topo II) inhibitor for MCF-7 cells with IC50 of 3.3 ng/mL in a cell-free assay.
Statement:
->>Products covered by valid patents are not offered or supplied for commercial use.
->>Products currently covered by valid US Patents are offered for laboratory R&D use in accordance with 35 USC 271(e)+A13(1).
->>Any patent infringement and resulting liability is solely at buyer's risk.
->>Our products are only raw materials for drugs or industry, can't be used for human or animals directly.